Skip to main content

Table 1 Baseline parameters in patients with CRVO

From: Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety

  Dexamethasone (n = 20) Triamcinolone acetonide (n = 20)
Sex (M/F) 12/8 9/11
Mean age (years ± SD) 58.6 ± 10.41 57.9 ± 8.77
Smoker (n) 8 9
Hypertension (n) 4 6
Hyperlipidemia (n) 3 4
Follow up (months ± SD) 6 6
BCVA (logMAR ± SD) 1.06 ± 0.13 0.99 ± 0.15
CMT (µm ± SD) 551 ± 17.16 547.5 ± 13.79
IOP (mmHg ± SD) 16.7 ± 1.16 16.1 ± 2.60
  1. BCVA best-corrected visual acuity, CMT central macular thickness, IOP intraocular pressure, NS not significant